IK
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prophylaxie et traitement par isavuconazole chez les receveurs de cellules souches hématopoïétiques allogéniques | 2025 | 37 | 83 | ||||
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | 2025 | 5 | 18 | |||
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | 2024 | 81 | 158 | |||
| Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers | PLOS ONE | 2021 | 361 | 442 | |||
| Novel SARS-CoV-2 variants: the pandemics within the pandemic | Clinical Microbiology and Infection | 2021 | 271 | 394 | |||
| Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2 | PLOS ONE | 2021 | 319 | 148 | |||
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | 2021 | 243 | 194 | |||
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | 2021 | 249 | 402 | |||
| Guillain-Barré syndrome as a complication of SARS-CoV-2 infection | Brain, behavior, and immunity | 2020 | 264 | 131 | |||
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | 2020 | 462 | 135 | |||
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation | 2020 | 347 | 1 | |||
| Quelle place pour les stéroïdes dans le traitement des maladies infectieuses ? | Revue médicale suisse | 2013 | 681 | 491 |
